Image

PRevalence Of Transient Global Amnesia in Obstructive Sleep Apnea Syndrome

PRevalence Of Transient Global Amnesia in Obstructive Sleep Apnea Syndrome

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Amnesic stroke is an amnestic syndrome lasting less than 24 hours characterized by the occurrence of anterograde amnesia often associated with retrograde amnesia, the pathophysiology of which is still poorly understood at present. A recent study on a small sample size (N=29) highlighted an association between obstructive sleep apnea syndrome and amnesic stroke. Our study seeks to confirm or refute these results on a larger cohort (N=200-250). A better understanding of the pathophysiological processes involved would open up new therapeutic avenues.

Eligibility

Inclusion Criteria:

  • Adult patients seen for consultation in the Neuropsychology Department of Strasbourg University Hospital between March 1, 2015 and December 31, 2021 following an episode of amnestic stroke meeting the Hodges and Warlow criteria:
  • The stroke must have been documented and reported by a competent witness present during the stroke.
  • Anterograde amnesia during the stroke.
  • Absence of vigilance, personality, and cognitive disorders other than memory disorders (aphasia, apraxia, etc.).
  • Absence of focal neurological symptoms during the episode and its aftermath.
  • Absence of epileptic manifestations.
  • Resolution of the episode in less than 24 hours.
  • Exclusion of patients with a history of recent head trauma or active epilepsy (undergoing regular treatment or having experienced a seizure in the last 2 years).
  • Subjects who have not expressed opposition to the reuse of their data for scientific research purposes.

Exclusion Criteria:

  • Patients who have expressed opposition to the retrospective reuse of their data for scientific research purposes.
  • Patients with active epilepsy
  • Patients with recent head trauma
  • Patients with an MMS < or equal to 25
  • Subject under guardianship or curatorship
  • Subject under judicial protection

Study details
    Transient Global Amnesia

NCT06903026

University Hospital, Strasbourg, France

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.